Xponance, Inc. Pfizer Inc Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Xponance, Inc. holds 816,904 shares of PFE stock, worth $21.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

816,904

Previous 888,632 8.07%

Holding current value

$21.8 Million

Previous $24.9 Million 4.91%

% of portfolio

0.23%

Previous 0.26%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $1.99 Million - $2.25 Million	-71,728 Reduced 8.07%	816,904 $23.6 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $1.27 Million - $1.49 Million	-50,202 Reduced 5.35%	888,632 $24.9 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $1.24 Million - $1.42 Million	47,810 Added 5.37%	938,834 $26.1 Million
Q4 2023 Jan 31, 2024	BUY	$26.13 - $33.94 $2.4 Million - $3.12 Million	91,843 Added 11.49%	891,024 $25.7 Million
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $1.96 Million - $2.29 Million	61,069 Added 8.27%	799,181 $26.5 Million
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $12,100 - $13,999	335 Added 0.05%	738,112 $27.1 Million
Q1 2023 Apr 17, 2023	BUY	$39.39 - $51.28 $1.48 Million - $1.92 Million	37,525 Added 5.36%	737,777 $30.1 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $4.26 Million - $5.56 Million	102,024 Added 17.05%	700,252 $0
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $3.58 Million - $4.37 Million	81,844 Added 15.85%	598,228 $26.2 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $551,147 - $653,488	-11,845 Reduced 2.24%	516,384 $27.1 Million
Q1 2022 Apr 20, 2022	BUY	$45.75 - $56.69 $324,413 - $401,988	7,091 Added 1.36%	528,229 $27.3 Million
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $4.35 Million - $6.45 Million	105,259 Added 25.31%	521,138 $30.8 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $1.08 Million - $1.38 Million	-27,461 Reduced 6.19%	415,879 $17.9 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $1.54 Million - $1.75 Million	-42,975 Reduced 8.84%	443,340 $17.4 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $33,356 - $37,618	996 Added 0.21%	486,315 $17.6 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $190,946 - $242,804	5,705 Added 1.19%	485,319 $17.9 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $1.75 Million - $2.06 Million	-55,270 Reduced 10.33%	479,614 $17.6 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $16.1 Million - $19.5 Million	534,884 New	534,884 $17.5 Million

Others Institutions Holding PFE

# of Institutions

3,257

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account